Impact of SARS-CoV2 infection on gut microbiota dysbiosis
Microbiome Research Reports · 06.12.2023 · 3 (1)
DOI: 10.20517/mrr.2023.48 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbiome Research Reports, online erschienen am 06.12.2023. Verfasst von Zhenming Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College & National Clinical Research Center for Agin…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The composition and function of the gut microbiota constantly influence health. Disruptions in this delicate balance, termed gut microbiota dysbiosis, have been implicated in various adverse health events. As the largest global epidemic since 1918, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had devastating consequences. While the primary impact of Corona Virus Disease 2019 (COVID-19) has been on the respiratory system, a growing body of research has unveiled the significant involvement of the gastrointestinal tract as well. Emerging evidence underscores notable alterations in the gut microbiome of COVID-19 patients. In addition, the gut microbiome is also characterized by an abundance of opportunistic pathogens, which is related to disease manifestations of COVID-19 patients. The intricate bidirectional interaction between the respiratory mucosa and the gut microbiota, known as the gut-lung axis, emerges as a crucial player in the pathological immune response triggered by SARS-CoV-2. Here, we discuss microbiota-based gut characteristics of COVID-19 patients and the long-term consequences of gut microbiota dysregulation. These insights could potentially transform the development of long-term interventions for COVID-19, offering hope for improved outcomes and enhanced patient recovery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Medical Molecular Virology, School of Basic Medical Sciences, Shanghai Medical College & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Shanghai Medical College, Fudan Univ…
- Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Frontiers Science Center, Shanghai 200032, China.
Zitieren
APA
Xiao, Z., Pan, M., Li, X., & Zhao, C. (2023). Impact of SARS-CoV2 infection on gut microbiota dysbiosis. Microbiome Research Reports, 3(1). https://doi.org/10.20517/mrr.2023.48
Vancouver
Xiao Z, Pan M, Li X, Zhao C. Impact of SARS-CoV2 infection on gut microbiota dysbiosis. Microbiome Research Reports. 2023;3(1). doi:10.20517/mrr.2023.48
BibTeX
@article{Xiao2023,
author = {Xiao, Zhenming and Pan, Miaomiao and Li, Xinyao and Zhao, Chao},
title = {Impact of SARS-CoV2 infection on gut microbiota dysbiosis},
journal = {Microbiome Research Reports},
year = {2023},
volume = {3},
number = {1},
doi = {10.20517/mrr.2023.48}
}
EUVIMED